预防性内镜下胆囊支架置入预防远端胆道梗阻覆膜金属支架置入后胆囊炎(附视频)
本研究回顾性分析2014年11月至2021年10月间286例因远端胆道梗阻置入覆膜自膨式金属支架(CSEMS)且胆道引流阴性胆囊炎的患者,比较置入前尝试预防性内镜下胆囊支架置入(EGBS)与否的胆囊炎发生率。EGBS组胆囊炎累积发生率显著低于非EGBS组(1例[4.2%] vs 56例[21.4%],P=.045),多变量分析显示EGBS为显著保护因素(HR .11,95%CI .01-.79,P=.028)。
要点
- EGBS技术成功率75%(24/32),不良事件发生率9.4%(3/32)。
- EGBS组胆囊炎累积发生率4.2%(1例) vs 非EGBS组21.4%(56例),P=.045。
- 多变量分析EGBS为胆囊炎显著保护因素(HR .11,95%CI .01-.79,P=.028)。
核心结论
- 尽管经乳头途径进入胆囊在远端胆道梗阻患者中并不容易,EGBS可有效预防CSEMS置入相关胆囊炎。
研究设计与样本
- 回顾性分析2014年11月至2021年10月间因远端胆道梗阻置入CSEMS跨越胆囊管开口且胆道引流阴性胆囊炎的患者286例(男128例;中位年龄75岁)。
- 在CSEMS置入前尝试预防性EGBS,比较有与无EGBS患者的胆囊炎发生率。
主要发现
- 32例患者在CSEMS置入前尝试EGBS,技术成功24例(75%)。
- 3例(9.4%)发生不良事件:胆囊管穿孔1例,急性胰腺炎2例。
- EGBS组胆囊炎累积发生率显著低于非EGBS组(1例[4.2%] vs 56例[21.4%],P=.045)。
- 多变量分析中EGBS为胆囊炎的显著保护因素(HR .11,95%CI .01-.79,P=.028)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Acute cholecystitis is occasionally observed after biliary drainage using a covered self-expandable metal stent (CSEMS) for distal biliary obstruction (DBO). Gallbladder drainage before CSEMS placement may reduce cholecystitis. This study aimed to examine the preventive effect of endoscopic gallbladder stent placement (EGBS) on cholecystitis with CSEMSs. METHODS: We retrospectively analyzed patients with DBO who underwent CSEMS placement across the orifice of the cystic duct between November 2014 and October 2021 and were negative for cholecystitis on biliary drainage. Prophylactic EGBS was attempted before CSEMS placement. The incidence of cholecystitis was compared between patients with and without EGBS. RESULTS: In total, 286 patients (128 men; median age, 75 years) were included in this study. EGBS was attempted in 32 patients before CSEMS placement, and technical success was achieved in 24 patients (75%). Adverse events were noted in 3 patients (9.4%; penetration of cystic duct in 1 and acute pancreatitis in 2). The cumulative incidence of cholecystitis was significantly lower in patients with EGBS than in those without EGBS (1 [4.2%] vs 56 [21.4%], P = .045). In multivariable analysis, EGBS was a significant protective factor against cholecystitis (hazard ratio, .11; 95% confidence interval, .01-.79; P = .028). CONCLUSIONS: Although the transpapillary approach to the gallbladder is not easy for patients with DBO, EGBS is effective in preventing cholecystitis associated with CSEMS placement.
引用
- Ishii T, Kin T, Yamazaki H, et al. Prophylactic endoscopic gallbladder stent placement for cholecystitis after covered metal stent placement for distal biliary obstruction (with video). Gastrointest Endosc. 2023. PMID: 36646149. doi:10.1016/j.gie.2023.01.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。